SOLICITATION NOTICE
R -- A State-Based Model for Buprenorphine Substance Training
- Notice Date
- 6/10/2004
- Notice Type
- Solicitation Notice
- NAICS
- 541990
— All Other Professional, Scientific, and Technical Services
- Contracting Office
- Department of Health and Human Services, Program Support Center, Division of Acquisition Management, Parklawn Building Room 5-101 5600 Fishers Lane, Rockville, MD, 20857
- ZIP Code
- 20857
- Solicitation Number
- Reference-Number-04M000135
- Response Due
- 6/24/2004
- Point of Contact
- Darren Jansen, Contract Specialist, Phone 301-443-1857, Fax 301-443-3238, - Joe Pirrone, Contracting Officer, Phone 301-443-4852, Fax 301-443-3238,
- E-Mail Address
-
djansen@psc.gov, jpirrone@psc.gov
- Description
- SIMPLIFIED ACQUISITION PROCEDURES DATE: JUNE 10, 2004 REQUISITION NO: 04M000135 INTENDED SOURCE: VIRGINIA COMMONWEALTH UNIVERSITY PERIOD OF PERFORMANCE: DATE OF AWARD THROUGH ONE YEAR PURPOSE: THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (DHHS), SUBSTANCE ABUSE AND MENTAL HEALTH SERVICES ADMINISTRATION (SAMHSA) THROUGH THE PROGRAM SUPPORT CENTER-DIVISION OF ACQUISITION MANAGEMENT PLANS TO AWARD A SOLE SOURCE SIMPLIFIED ACQUISITION TO VIRGINIA COMMONWEALTH UNIVERSITY. CLOSING DATE IS JUNE 24, 2004 THE SPECIFIC OBJECTIVE OF THIS PROCUREMENT IS TO: PURPOSE: TO PROVIDE TECHNICAL ASSISTANCE TO THE CENTER FOR SUBSTANCE ABUSE TREATMENT IN EDUCATING HEALTH CARE PROVIDERS WITH TREATMENT ISSUES SURROUNDING BUPRENORPHINE BY IMPLEMENTING A PROCESS OF INTEGRATING OPIOID ADDICTION TREATMENT INTO MAINSTREAM MEDICAL PRACTICE AND SPECIFICALLY, BUPRENORPHINE TREATMENT FOR OPIOID DEPENDENCE BY THE FACILITATION OF THE DEVELOPMENT OF NEW MODELS AIMED AT INCREASING PROVIDER KNOWLEDGE AND ENDORSEMENT OF THIS TYPE OF TREATMENT OPTION. BACKGROUND: ACCORDING TO THE OFFICE OF NATIONAL DRUG CONTROL POLICY (ONDCP), THERE WERE AN ESTIMATED 810,000 TO 1,000,000 INDIVIDUALS ADDICTED TO HEROIN IN THE UNITED STATES IN THE YEAR 2000-WHICH IS THE HIGHEST NUMBER SINCE THE MID-TO-LATE 1970S. NATIONALLY, OPIOID ANALGESICS WERE INVOLVED IN 14 PERCENT OF ALL DRUG-ABUSE RELATED EMERGENCY DEPARTMENT VISITS IN 2001 BASED ON DATA FROM THE SUBSTANCE ABUSE AND MENTAL HEALTH SERVICES ADMINISTRATION. AN INCREASE IN THE RATES OF INJECTION DRUG USE HAS A SIGNIFICANT EFFECT ON THE INCIDENCE OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION, HEPATITIS B AND C, AND OTHER INFECTIOUS DISEASES. HISTORICALLY, A SIGNIFICANT BREAKTHROUGH IN THE TREATMENT OF OPIOID ADDICTION OCCURRED WITH THE INTRODUCTION OF METHADONE IN THE 1960S. METHADONE MAINTENANCE PROVED SAFE AND EFFECTIVE AND ENABLED PATIENTS TO LEAD FUNCTIONAL LIVES. WITHIN A FEW YEARS OF ITS INTRODUCTION, NEW LAWS AND REGULATIONS EFFECTIVELY LIMITED METHADONE MAINTENANCE TREATMENT TO THE CONTEXT OF OPIOID TREATMENT PROGRAM (OTP) SETTINGS. THE NEW SYSTEM MADE IT DIFFICULT FOR PHYSICIANS TO USE METHADONE TO TREAT OPIOID ADDICTION IN AN OFFICE-BASED SETTING OR IN A GENERAL DRUG REHABILITATION PROGRAM. EFFORTS TO RETURN OPIOID ADDICTION TREATMENT TO THE MAINSTREAM OF MEDICAL CARE BEGAN TO TAKE SHAPE IN THE 1990S. IN OCTOBER 2000, THE CHILDREN'S HEALTH ACT OF 2000 WAS ENACTED INTO LAW. TITLE XXV OF THE ACT PROVIDES A WAIVER AUTHORITY FOR PHYSICIANS WHO DISPENSE OR PRESCRIBE CERTAIN NARCOTIC DRUGS FOR MAINTENANCE TREATMENT OR DETOXIFICATION TREATMENT OF OPIOID-DEPENDENT PATIENTS. THIS PART OF THE LAW IS KNOWN AS THE DRUG ADDICTION TREATMENT ACT OF 2000. FEDERAL LEGISLATION, TITLED THE DRUG ADDICTION TREATMENT ACT OF 2000, HAS ESTABLISHED A NEW PARADIGM FOR THE MEDICATION-ASSISTED TREATMENT OF OPIOID DEPENDENCE IN THE UNITED STATES. NOW UNDER THE PROVISIONS OF DATA 2000, QUALIFYING PHYSICIANS IN MEDICAL OFFICES AND OTHER APPROPRIATE SETTINGS OUTSIDE OF THE OPIOID TREATMENT PROGRAM SYSTEM MAY PRESCRIBE OR DISPENSE SCHEDULE III, IV, AND V OPIOID MEDICATION FOR THE TREATMENT OF OPIOID DEPENDENCE IF SUCH MEDICATIONS HAVE BEEN SPECIFICALLY APPROVED BY THE FOOD AND DRUG ADMINISTRATION (FDA) FOR THAT INDICATION. THE DRUG ABUSE TREATMENT ACT OF 2000 PROVIDES EXPANDED WAIVER AUTHORITY FOR PHYSICIANS WHO DISPENSE OR PRESCRIBE CERTAIN NARCOTIC DRUGS FOR MAINTENANCE OR DETOXIFICATION TREATMENT OF OPIATE ADDICTION WITH THE GOAL OF EXPANDING ACCESS TO AND EFFECTIVE TREATMENT OF OPIOID DEPENDENCE AND TO BEGIN TO NORMALIZE IT WITHIN HEALTHCARE BY PROVIDING FOR OFFICE-BASED TREATMENT. PHYSICIANS MUST BE QUALIFIED FOR THE WAIVER; FOR MOST OF IT INVOLVES PARTICIPATION IN AN APPROVED 8-HOUR TRAINING COURSE. OBJECTIVES: TO IMPLEMENTING A PROCESS OF INTEGRATING OPIOID ADDICTION TREATMENT INTO MAINSTREAM MEDICAL PRACTICE BY DEVELOPING NEW MODELS OF INCREASING PROVIDER KNOWLEDGE AND USE OF TREATING OPIOID ADDICTION VIA BURPENORPHINE. TO PROVIDE TRAININGS THAT WILL EDUCATE PHYSICIANS AND CLINICIANS IN THE PRACTICAL USE OF BUPRENORPHINE IN OFFICE-BASED SETTINGS. TO DEVELOPE A FOUR-PRONG APPROACH AIMED AT DEVELOPING A STATE-BASED PROGRAM OF EDUCATION THAT WILL INCREASE THE NUMBER OF WAIVER-ELIGIBLE PHYSICIANS. TO FURNISH CSAT WITH A REPORT DETAILING THE CONTRACTOR'S ASSESSMENT AND EVALUATION OF THE PROGRAM. DESCRIPTION OF WORK: GENERAL REQUIREMENTS: THE CONTRACTORS SHALL FURNISH THE NECESSARY PERSONNEL, FACILITIES, EQUIPMENT, MATERIALS, AND SUPPLIES AND PERFORM THE WORK SET FORTH BELOW; SPECIFIC REQUIREMENTS: TASK 1: TO DEVELOP A FOUR-PRONGED APPROACH AIMED AT DEVELOPING A STATE-BASED PROGRAM OF EDUCATION THAT WILL INCREASE THE NUMBER OF WAIVER-ELIGIBLE PHYSICIANS IN THE STATE OF VIRGINIA AND THE DISTRICT OF COLUMBIA. TASK 2: TO COORDINATE AND DELIVER FREE BUPRENORPHINE TRAININGS UTILIZING A CSAT-APPROVED CURRICULUM THAT WILL TAKE PLACE AT FOUR VIRGINIA MEDICAL SCHOOLS DURING EACH YEAR OF SUPPORT. TASK 3: TO PROVIDE TRAINING SETTINGS THAT CAN BE EASILY ACCESSED BY PRACTITIONERS IN VIRGINIA AND DISTRICT OF COLUMBIA. TASK 4: TO MARKET THE TRAININGS TO LOCAL PHYSICIANS, RESIDENTS, AND MEDICAL STUDENTS WITHIN THE STATE OF VIRGINIA AND DISTRICT OF COLUMBIA. TASK 5: TO PROVIDE TRAININGS THAT WILL BE ABLE TO EDUCATE PHYSICIANS AND CLINICIANS IN THE PRACTICAL USE OF BUPRENORPHINE IN OFFICE-BASED PRACTICE BY DEMONSTRATING AND REVIEWING A HANDS-ON SETTING IN WHICH THE CLINICIAN WILL OBSERVE THE PROCESS OF INDUCTION ON BUPRENORPHINE INCLUDING THE PATIENT INTERVIEW, ELIGIBILITY, DOCUMENTATION REQUIREMENTS, OPIATE WITHDRAWAL ASSESSMENT, BUPRENORPHINE DOSING, AND ADMINISTRATIVE ASPECTS OF BUPRENORPHINE TREATMENT IN AN OFFICE BASED SETTING. TASK 6: TO PROVIDE BUPRENORPHINE EXPERT ADVICE AND SUPPORT TO PRACTITIONERS WHO COMPLETE THE BUPRENORPHINE TRAINING VIA TELEPHONE AND EMAIL COMMUNICATIONS. TASK 7: TO PROVIDE A PROGRAM EVALUATION OF THE PROGRAM THAT WILL INCLUDE SURVEYS OF CLINICIANS COMPLETING THE OFFERED TRAINING TO DETERMINE PERCEPTION OF TRAINING QUALITY, LIKELIHOOD OF UNDERTAKING PRACTICE WITH BUPRENORPHINE, BARRIERS TO BUPRENORPHINE PRACTICE, NUMBERS OF TRAINEES WHO OBTAIN WAIVERS, NUMBER OF PHYSICIANS PRESCRIBING BUPRENORPHINE, AND TREATMENT RENDERED. TASK 8: TO PROVIDE A MONOGRAPH DESCRIBING THE PROGRAM AND ITS RESULTS. SOLE SOURCE DETERMINATION IS BASED UPON THE FOLLOWING: ON OCTOBER 17, 2000, THE CHILDREN'S HEALTH ACT OF 2000 WAS SIGNED INTO FEDERAL LAW. SECTION 3502 OF THAT ACT SETS FORTH THE DRUG ADDICTION TREATMENT ACT OF 2000 (DATA). THIS LEGISLATION IS OF PARTICULAR INTEREST TO STATE MEDICAL BOARDS BECAUSE IT PROVIDES FOR SIGNIFICANT CHANGES IN THE OVERSIGHT OF THE MEDICAL TREATMENT OF OPIOID ADDICTION. FOR THE FIRST TIME IN ALMOST A CENTURY, PHYSICIANS MAY TREAT OPIOID ADDICTION WITH OPIOID MEDICATIONS IN OFFICE-BASED SETTINGS. THESE OPIOID MEDICATIONS, SCHEDULES III, IV, AND V OPIOID DRUGS WITH FOOD AND DRUG ADMINISTRATION (FDA) APPROVED INDICATION FOR THE TREATMENT OF OPIOID DEPENDENCE, MAY BE PROVIDED TO PATIENTS UNDER CERTAIN RESTRICTIONS. THIS NEW TREATMENT MODALITY MAKES IT POSSIBLE FOR PHYSICIANS TO TREAT PATIENTS FOR OPIOID ADDICTION IN THE PHYSICIAN'S OFFICE WITH THESE SCHEDULE III-V NARCOTIC CONTROLLED SUBSTANCES SPECIFICALLY APPROVED BY THE FDA FOR ADDICTION TREATMENT. PREVIOUSLY, FEDERAL REGULATIONS REQUIRED THAT PATIENTS RECEIVING THIS TYPE OF TREATMENT BE REFERRED TO SPECIALIZED OPIOID TREATMENT PROGRAMS (OTPS). TO QUALIFY FOR A WAIVER UNDER DATA 2000 A LICENSED PHYSICIAN (MD OR DO) MUST MEET ANY ONE OR MORE OF THE FOLLOWING (1) THE PHYSICIAN HOLDS A SUBSPECIALTY BOARD CERTIFICATION IN ADDICTION PSYCHIATRY FROM THE AMERICAN BOARD OF MEDICAL SPECIALTIES, (2) THE PHYSICIAN HOLDS AN ADDICTION CERTIFICATION FROM THE AMERICAN SOCIETY OF ADDICTION MEDICINE, (3) THE PHYSICIAN HOLDS A SUBSPECIALTY BOARD CERTIFICATION IN ADDICTION MEDICINE FROM THE AMERICAN OSTEOPATHIC ASSOCIATION, (4) THE PHYSICIAN HAS, WITH RESPECT TO THE TREATMENT AND MANAGEMENT OF OPIOID-ADDICTED PATIENTS, COMPLETED NOT LESS THAN EIGHT HOURS OF TRAINING (THROUGH CLASSROOM SITUATIONS, SEMINARS AT PROFESSIONAL SOCIETY MEETINGS, ELECTRONIC COMMUNICATIONS, OR OTHERWISE) THAT IS PROVIDED BY THE AMERICAN SOCIETY OF ADDICTION MEDICINE, THE AMERICAN ACADEMY OF ADDICTION PSYCHIATRY, THE AMERICAN MEDICAL ASSOCIATION, THE AMERICAN OSTEOPATHIC ASSOCIATION, THE AMERICAN PSYCHIATRIC ASSOCIATION, OR ANY OTHER ORGANIZATION THAT THE SECRETARY DETERMINES IS APPROPRIATE FOR PURPOSES OF THIS SUBCLAUSE, (5) THE PHYSICIAN HAS PARTICIPATED AS AN INVESTIGATOR IN ONE OR MORE CLINICAL TRIALS LEADING TO THE APPROVAL OF A NARCOTIC DRUG IN SCHEDULE III, IV, OR V FOR MAINTENANCE OR DETOXIFICATION TREATMENT, AS DEMONSTRATED BY A STATEMENT SUBMITTED TO THE SECRETARY BY THE SPONSOR OF SUCH APPROVED DRUG, (6) THE PHYSICIAN HAS SUCH OTHER TRAINING OR EXPERIENCE AS THE STATE MEDICAL LICENSING BOARD (OF THE STATE IN WHICH THE PHYSICIAN WILL PROVIDE MAINTENANCE OR DETOXIFICATION TREATMENT) CONSIDERS TO DEMONSTRATE THE ABILITY OF THE PHYSICIAN TO TREAT AND MANAGE OPIOID-ADDICTED PATIENTS, AND (7) THE PHYSICIAN HAS SUCH OTHER TRAINING OR EXPERIENCE AS THE SECRETARY CONSIDERS TO DEMONSTRATE THE ABILITY OF THE PHYSICIAN TO TREAT AND MANAGE OPIOID-ADDICTED PATIENTS. DATA REQUIRES CHANGES IN THE OVERSIGHT SYSTEMS WITHIN THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS) AND THE DRUG ENFORCEMENT ADMINISTRATION (DEA). THE SECRETARY OF HHS HAS DELEGATED ADMINISTRATIVE AUTHORITY IN THIS AREA TO THE SUBSTANCE ABUSE AND MENTAL HEALTH SERVICES ADMINISTRATION (SAMHSA). BRINGING THE TREATMENT OF OPIOID ADDICTED PATIENTS INTO THE SCOPE OF INDIVIDUAL PHYSICIAN PRACTICE SIGNIFICANTLY INCREASES THE ROLE OF THE STATE MEDICAL BOARD IN OVERSEEING OPIOID ADDICTION TREATMENT. FOR THIS REASON, THE FEDERATION OF STATE MEDICAL BOARDS (FSMB) ENTERED INTO AN AGREEMENT WITH CSAT TO DEVELOP MODEL GUIDELINES FOR USE BY STATE MEDICAL BOARDS IN REGULATING THE OFFICE-BASED TREATMENT OF OPIOID ADDICTION. DATA ALSO PERMITS STATE MEDICAL LICENSING BOARDS TO DETERMINE TRAINING AND EXPERIENCE REQUIREMENTS THAT CAN QUALIFY A PHYSICIAN AS HAVING THE ABILITY TO TREAT AND MANAGE OPIATE DEPENDENT PATIENTS. THE FSMB MODEL GUIDELINES ARE DESIGNED TO ENCOURAGE STATE MEDICAL BOARDS TO ADOPT CONSISTENT STANDARDS, PROMOTE PUBLIC HEALTH BY AVAILING OPIOID ADDICTED PATIENTS OF APPROPRIATE TREATMENT, AND EDUCATING THE REGULATORY AND PHYSICIAN COMMUNITIES ON NEW TREATMENT MODALITIES OFFERING AN ALTERNATIVE IN THE TREATMENT OF OPIOID ADDICTION. IN THAT REGARD, VIRGINIA COMMONWEALTH UNIVERSITY AND ELIZABETH MCCANCE-KATZ ARE THE SOLE SOURCE TO EDUCATE MEDICAL AND OSTEOPATHIC PHYSICIANS IN VIRGINIA BECAUSE OF THEIR KNOWLEDGE OF THE DATA REQUIREMENTS, RELATIONSHIP WITH DATA QUALIFYING GROUPS, EDUCATIONAL BACKGROUND IN BUPRENORPHINE TRAINING DEVELOPMENT, AND EXPERTISE IN STATE MEDICAL BOARD DEVELOPMENT OF POLICY IN PRESCRIBING BUPRENORPHINE. THEY ARE THE SOLE SOURCE CAPABLE OF PERFORMING THE TASKS NECESSARY FOR COMPLETION OF THIS CONTRACT, SPECIFICALLY, THE PLANNING, DEVELOPMENT OF PHYSICIAN TRAININGS, AND CONTINUAL SUPPORT OF TRAINED PHYSICIANS PRESCRIBING BUPRENORPHINE. DR. MCCANCE-KATZ IS UNIQUELY QUALIFIED TO SEE THAT THE TRAINING IS INCORPORATED INTO THE MEDICAL FACILITIES ACROSS THE STATE. SHE HAS PROVIDED SIGNIFICANT OVERSIGHT TO THE DEVELOPMENT OF THE NEW DHHS/SAMHSA TREATMENT IMPROVEMENT PROTOCOL TITLED "CLINICAL GUIDELINES FOR THE USE OF BUPRENORPHINE IN THE TREATMENT OF OPIOID ADDICTION," BY SERVING ON THE BUPRENORPHINE ADVISORY BOARD. DR. MCCANCE-KATZ CURRENTLY SERVES AS VICE-PRESIDENT OF THE AMERICAN ACADEMY OF ADDICTION PSYCHIATRY, WHICH IS ONE OF THE FIVE PROFESSIONAL DATA ORGANIZATIONS DESIGNATED BY FEDERAL MANDATES TO TRAIN PHYSICIANS IN EIGHT HOURS OF COURSEWORK IN BUPRENORPHINE. THIS SIMPLIFIED ACQUISITION WILL BE ISSUED ON A SOLE-SOURCE BASIS IN THE INTEREST OF ECONOMY, EFFICIENCY, AND EFFECTIVENESS. THE WORK DESCRIBED IN THIS ACQUISITION IS LOGICALLY CONSISTENT WITH WORK THAT THE PROPOSED CONTRACTOR HAS UNDERTAKEN INDEPENDENTLY IN THE PAST. THIS UNIVERSITY HAS THE TRUST OF THE TREATMENT FIELD IN VIRGINIA AND HAS ESTABLISHED AND MAINTAINED THE CONTACTS AND INFLUENCE, NOT ONLY WITH THE OPIOID AGONIST TREATMENT FIELD, BUT ALSO WITH THE REPRESENTATIVES AND LEADERS IN THE MEDICAL FIELD AND TRAINING INSTITUTIONS. THE UNIVERSITY HAS ALSO WORKED SUCCESSFULLY WITH DEVELOPING MEDICALLY FOCUSED EDUCATIONAL OFFERINGS AND PROJECTS IN THE PAST. THE PROPOSED SIMPLIFIED ACQUISITION IS FOR SERVICES FOR WHICH THE GOVERNMENT INTENDS TO SOLICIT AND NEGOTIATE WITH ONLY ONE SOURCE (FAR 6.302-1). A DETERMINATION BY THE GOVERNMENT NOT TO COMPETE THIS PROPOSED SIMPLIFIED ACQUISITION BASED UPON RESPONSES TO THIS NOTICE IS SOLELY WITHIN THE DISCRETION OF THE GOVERNMENT. CONTRACTORS MAY FORWARD CAPABILITY STATEMENTS TO THE REFERENCED ADDRESS. INFORMATION RECEIVED WILL NORMALLY BE CONSIDERED SOLELY FOR THE PURPOSES OF DETERMINING WHETHER TO CONDUCT A COMPETITIVE PROCUREMENT. FOR FURTHER INFORMATION, PLEASE CONTACT DARREN JANSEN, IN ROOM 5C-13, PARKLAWN BLDG., 5600 FISHERS LANE, ROCKVILLE, MD 20857 OR ON 301-443-1857.
- Record
- SN00601757-W 20040612/040610211844 (fbodaily.com)
- Source
-
FedBizOpps.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |